Skip to content

Neuronetics STIM Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Stereotaxis logo
StereotaxisSTXS
$4.85M+15,066%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$10K-97.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$23.6M-26.5%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$148K
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$2.84M-3.6%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's stock issuance proceeds?
Neuronetics (STIM) reported stock issuance proceeds of $20.7M in Q1 2025.
How has Neuronetics's stock issuance proceeds changed year-over-year?
Neuronetics's stock issuance proceeds increased by 8279900.0% year-over-year, from $250 to $20.7M.
What is the long-term trend for Neuronetics's stock issuance proceeds?
Over 2 years (2022 to 2024), Neuronetics's stock issuance proceeds has grown at a -94.2% compound annual growth rate (CAGR), from $298K to $1K.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.